BusinessActinium Announces Expansion of Intellectual Property Portfolio with Notice of Allowance for U.S. Patent Related to Actimab-A, Actimab-M and the Company’s Technology PlatformBy Nasdaq OMXFeb 28, 2017, 12:01 PM UTC
BusinessActinium Announces Expansion of Intellectual Property Portfolio with Notice of Allowance for U.S. Patent Related to Actimab-A, Actimab-M and the Company’s Technology PlatformBy Nasdaq OMXFeb 28, 2017, 12:01 PM UTC
BusinessActinium Pharmaceuticals Announces Hiring of Steven Price to Position of Vice President, Clinical and Commercial StrategyBy Nasdaq OMXFeb 21, 2017, 12:01 PM UTC
BusinessActinium Pharmaceuticals Announces Hiring of Steven Price to Position of Vice President, Clinical and Commercial StrategyBy Nasdaq OMXFeb 21, 2017, 12:01 PM UTC
BusinessActinium Pharmaceuticals to Present at Source Capital Group’s 2017 Disruptive Growth & Healthcare ConferenceBy Nasdaq OMXFeb 13, 2017, 9:15 PM UTC
BusinessPoseida Therapeutics Presents Preclinical Data Demonstrating Tumor Response from BCMA-Specific CAR-T Program at American Society of Hematology Annual MeetingBy Nasdaq OMXDec 5, 2016, 6:00 PM UTC
